Main Content

Reportable Cancer List DX 10/2006 or later

REPORTABLE CASES – MISSISSIPPI

For cases diagnosed 10/2006 or later

The following lists are intended to assist you, as the reporter, in identifying the reportable neoplasms for your facility. Any reportable neoplasms diagnosed on or after January 1, 1996 should be reported to the Mississippi Cancer Registry.

REPORTABLE NEOPLASMS

• Malignant neoplasms (exclusions noted below)
• Benign and borderline neoplasms of the central nervous system (Cases diagnosed on or after January 1, 2004)
• Carcinoma in-situ (exclusions noted below)
• Carcinoid, NOS (excluding appendix, unless stated to be malignant)
• Pilocytic/juvenile astrocytoma is listed as 9421/1 in ICD-O-3, is reportable, and should be coded to 9421/3.
• Squamous intraepithelial neoplasia grade III of vulva [VIN], vagina [VAIN], and anus [AIN] beginning with 2001 cases.

Note:

• Primary Tumors that originate in a mucous membrane are reportable and include the following: Lip, Anus, Labia, Clitoris, Vulva, Vagina, Prepuce, Penis, Scrotum
• Melanoma is reportable

NON-REPORTABLE NEOPLASMS

• Basal and squamous cell carcinomas of the skin (8090-8110)
• Epithelial carcinomas of the skin (8010-8045)
• Papillary and squamous cell carcinomas of the skin (8050-8084)
• Malignant neoplasms, NOS of the skin (8000-8004)
• Carcinoma in-situ of the cervix (8012)
• Intraepithelial neoplasms of the cervix (8077/2) or prostate (8148/2)
• Borderline cystadenomas (8442, 8451, 8462, 8472, 8473), of the ovaries with behavior code "1" are not collected as of January 1, 2001
• Cyst, brain or CNS tumor that does not have an ICD-O-3 code as of January 1, 2004

The following lists should aid the reporter in determining which admissions (inpatient and outpatient) should be reviewed for reportability.

* Note: This is an obsolete diagnostic term. The condition should be correctly coded to 205.0, acute myelogenous leukemia neoplasms.

The following are exclusions and do not need to be reported to the MCR.

AMBIGUOUS TERMINOLOGY

• If a cytology is reported as suspicious, do not interpret it as a diagnosis of cancer. Abstract the case only if a positive biopsy or a physician's clinical impression of cancer supports the cytology findings.
• Genetic findings in the absence of pathologic or clinical evidence of reportable disease are indicative of risk only and do not constitute a diagnosis.

There are other ambiguous terms used by physicians that are related to staging. Some may indicate tumor involvement or extension, while others are not considered to be involvement. Refer to Collaborative Staging Manual and Coding Instructions, page I-20, for a listing of those terms.